Header Logo

Connection

DONALD DONOVAN to Humans

Back to Details
This is a "connection" page, showing publications DONALD DONOVAN has written about Humans.
DONALD DONOVAN
Connection Strength
0.132
Humans
  1. Presentation and Management of Giant Fibrovascular Polyps of the Hypopharynx and Esophagus. Ann Otol Rhinol Laryngol. 2017 Jan; 126(1):29-35.
    View in: PubMed
    Score: 0.015
  2. Endoscopic management of Zenker's diverticulum: factors predictive of success or failure. Ann Otol Rhinol Laryngol. 2008 Jul; 117(7):531-7.
    View in: PubMed
    Score: 0.008
  3. Treatment of hypophonia with collagen vocal cord augmentation in patients with parkinsonism. Mov Disord. 2003 Oct; 18(10):1190-2.
    View in: PubMed
    Score: 0.006
  4. Molecular transformation of recurrent respiratory papillomatosis: viral typing and p53 overexpression. Ann Otol Rhinol Laryngol. 2003 Apr; 112(4):298-302.
    View in: PubMed
    Score: 0.006
  5. Comparative Treatment Outcomes for Idiopathic Subglottic Stenosis: 5-Year Update. Otolaryngol Head Neck Surg. 2023 06; 168(6):1570-1575.
    View in: PubMed
    Score: 0.006
  6. Inpatient Type 1 Thyroplasty Versus Injection Laryngoplasty for Vocal Fold Movement Impairment After Extent type I and II Aortic Repair. Ann Otol Rhinol Laryngol. 2022 Dec; 131(12):1340-1345.
    View in: PubMed
    Score: 0.005
  7. Association of Social Determinants of Health with Time to Diagnosis and Treatment Outcomes in Idiopathic Subglottic Stenosis. Ann Otol Rhinol Laryngol. 2021 Oct; 130(10):1116-1124.
    View in: PubMed
    Score: 0.005
  8. Percutaneous tracheotomy may be useful in both surgical and intensive care settings, but is no replacement for the open procedure. Arch Otolaryngol Head Neck Surg. 2001 Feb; 127(2):225-6.
    View in: PubMed
    Score: 0.005
  9. Comparative Treatment Outcomes for Patients With Idiopathic Subglottic Stenosis. JAMA Otolaryngol Head Neck Surg. 2020 01 01; 146(1):20-29.
    View in: PubMed
    Score: 0.005
  10. Early glottic cancer in a veteran population: Impact of race on management and outcomes. Laryngoscope. 2020 07; 130(7):1733-1739.
    View in: PubMed
    Score: 0.005
  11. Laryngopharyngeal reflux: a possible risk factor in laryngeal and hypopharyngeal carcinoma. Otolaryngol Head Neck Surg. 1999 Apr; 120(4):598-601.
    View in: PubMed
    Score: 0.004
  12. Incidence and Treatment Outcomes of Vocal Fold Movement Impairment After Total Arch Replacement. Laryngoscope. 2019 03; 129(3):699-703.
    View in: PubMed
    Score: 0.004
  13. Impaired ciliary clearance from tracheopathia osteoplastica of the upper respiratory tract. Otolaryngol Head Neck Surg. 1997 Dec; 117(6):S102-4.
    View in: PubMed
    Score: 0.004
  14. Pathologic quiz case 1. Malignant peripheral nerve sheath tumor of the ethmoidal sinus. Arch Otolaryngol Head Neck Surg. 1997 Jun; 123(6):654, 656-7.
    View in: PubMed
    Score: 0.004
  15. Botulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndrome. Mov Disord. 1996 Jul; 11(4):431-3.
    View in: PubMed
    Score: 0.004
  16. Long-term Voice Outcomes of Early Thyroplasty for Unilateral Vocal Fold Paralysis Following Aortic Arch Surgery. Ann Otol Rhinol Laryngol. 2016 Jul; 125(7):559-63.
    View in: PubMed
    Score: 0.004
  17. Tracheobronchopathia osteochondroplastica. Laryngoscope. 2016 09; 126(9):2006-9.
    View in: PubMed
    Score: 0.004
  18. Disease homogeneity and treatment heterogeneity in idiopathic subglottic stenosis. Laryngoscope. 2016 06; 126(6):1390-6.
    View in: PubMed
    Score: 0.003
  19. Routine computed tomography in the evaluation of vocal fold movement impairment without an apparent cause. Otolaryngol Head Neck Surg. 2015 Feb; 152(2):308-13.
    View in: PubMed
    Score: 0.003
  20. Causes and consequences of adult laryngotracheal stenosis. Laryngoscope. 2015 May; 125(5):1137-43.
    View in: PubMed
    Score: 0.003
  21. Isotretinoin therapy for recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg. 1994 Apr; 120(4):405-9.
    View in: PubMed
    Score: 0.003
  22. Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm. J Neurol Neurosurg Psychiatry. 1990 Aug; 53(8):633-9.
    View in: PubMed
    Score: 0.002
  23. Metastatic squamous cell carcinoma of the parotid: a case of an occult primary. Head Neck. 1990 Mar-Apr; 12(2):174-7.
    View in: PubMed
    Score: 0.002
  24. Neurotropic melanoma of the head and neck. Laryngoscope. 1985 Oct; 95(10):1161-6.
    View in: PubMed
    Score: 0.002
  25. Using technology to decrease xerostomia for head and neck cancer patients treated with radiation therapy. Semin Oncol. 2002 Dec; 29(6 Suppl 19):71-9.
    View in: PubMed
    Score: 0.001
  26. Long-term response of recurrent respiratory papillomatosis to treatment with lymphoblastoid interferon alfa-N1. Papilloma Study Group. N Engl J Med. 1991 Aug 29; 325(9):613-7.
    View in: PubMed
    Score: 0.001
  27. Does the severity of sinus computed tomography findings predict outcome in chronic sinusitis? Otolaryngol Head Neck Surg. 2000 Jul; 123(1 Pt 1):81-4.
    View in: PubMed
    Score: 0.001
  28. The use of intensity modulated radiotherapy for the treatment of extensive and recurrent juvenile angiofibroma. Int J Pediatr Otorhinolaryngol. 2000 May 30; 52(3):261-8.
    View in: PubMed
    Score: 0.001
  29. Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys. 1999 Aug 01; 45(1):21-32.
    View in: PubMed
    Score: 0.001
  30. Oncocytic mucoepidermoid carcinoma of the salivary glands. Am J Surg Pathol. 1999 May; 23(5):523-9.
    View in: PubMed
    Score: 0.001
  31. Aggressive cervical lymphoma presenting as airway obstruction. Otolaryngol Head Neck Surg. 1999 Apr; 120(4):610-3.
    View in: PubMed
    Score: 0.001
  32. Intensity-modulated radiotherapy: first results with this new technology on neoplasms of the head and neck. Ear Nose Throat J. 1999 Apr; 78(4):238, 241-6, 248 passim.
    View in: PubMed
    Score: 0.001
  33. The effects of a practice guideline on endoscopic sinus surgery at an academic center. Am J Rhinol. 1997 Mar-Apr; 11(2):161-5.
    View in: PubMed
    Score: 0.001
  34. Neuroendocrine neoplasms of the larynx. Laryngoscope. 1995 Aug; 105(8 Pt 1):789-94.
    View in: PubMed
    Score: 0.001
  35. Life-threatening presentations of fibrovascular esophageal and hypopharyngeal polyps. Ann Otol Rhinol Laryngol. 1994 Nov; 103(11):838-42.
    View in: PubMed
    Score: 0.001
  36. 13-Cis-retinoic acid plus interferon-alpha 2a in recurrent respiratory papillomatosis. J Natl Cancer Inst. 1994 Jun 01; 86(11):859-61.
    View in: PubMed
    Score: 0.001
  37. The silent sinus syndrome. A cause of spontaneous enophthalmos. Ophthalmology. 1994 Apr; 101(4):772-8.
    View in: PubMed
    Score: 0.001
  38. Clinical review 44: Medullary thyroid carcinoma: recent progress. J Clin Endocrinol Metab. 1993 Apr; 76(4):809-14.
    View in: PubMed
    Score: 0.001
  39. Characterization of the clinical features of five families with hereditary primary cutaneous lichen amyloidosis and multiple endocrine neoplasia type 2. Henry Ford Hosp Med J. 1992; 40(3-4):249-52.
    View in: PubMed
    Score: 0.001
  40. Neurologic aspects of spasmodic dysphonia. J Otolaryngol. 1990 Aug; 19(4):231-6.
    View in: PubMed
    Score: 0.001
  41. Multiple endocrine neoplasia type 2a associated with cutaneous lichen amyloidosis. Ann Intern Med. 1989 Nov 15; 111(10):802-6.
    View in: PubMed
    Score: 0.001
  42. Randomized surgical adjuvant trial of interferon alfa-n1 in recurrent papillomatosis. Arch Otolaryngol Head Neck Surg. 1988 Oct; 114(10):1163-9.
    View in: PubMed
    Score: 0.001
  43. Interferon alfa-n1 (Wellferon) in juvenile onset recurrent respiratory papillomatosis: results of a randomized study in twelve collaborative institutions. Laryngoscope. 1988 Mar; 98(3):334-40.
    View in: PubMed
    Score: 0.001
  44. Prevalence of human papillomavirus in inverted nasal papillomas. Arch Otolaryngol Head Neck Surg. 1988 Jan; 114(1):23-6.
    View in: PubMed
    Score: 0.001
  45. Tumors of the parapharyngeal space. Arch Otolaryngol. 1985 Nov; 111(11):753-7.
    View in: PubMed
    Score: 0.000
  46. Further observations on the treatment of recurrent respiratory papillomatosis with interferon: a comparison of sources. Ann Otol Rhinol Laryngol. 1983 Sep-Oct; 92(5 Pt 1):456-61.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.